Sonnet Biotherapeuti Xxxcontingenet Value Right Eff: 12/03/2025
13F holders, Q1 2026 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Sonnet Biotherapeuti Xxxcontingenet Value Right Eff: 12/03/2025 in their 13F filings. The largest holder was Ascentis Independent Advisors ($0).
- Company
- Sonnet Biotherapeuti Xxxcontingenet Value Right Eff: 12/03/2025
- CUSIP
- 835CVR028
- Latest filing quarter
- Q1 2026
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Ascentis Independent Advisors | 0.00% | New | 625 | $0 |
"% of holder's portfolio" is SONNET BIOTHERAPEUTI XXXCONTINGENET VALUE RIGHT EFF: 12/03/2025's weight in each manager's 13F, not the share of Sonnet Biotherapeuti Xxxcontingenet Value Right Eff: 12/03/2025 the manager owns.